NDAORAL-28TABLET
Approved
Nov 1995
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Mechanism of Action
Estrogen Receptor Agonists
Pharmacologic Class:
Estrogen
Clinical Trials (4)
Study Comparing Premarin®/MPA, PREMPRO® and Provera® in Healthy Postmenopausal Women
Started Oct 2007
30 enrolled
Postmenopause
Bioequivalence Study of 3 New Formulations of Premarin/MPA Compared With Premarin/MPA (Prempro)
Started May 2007
Postmenopause
Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension
Started Jan 2007
92 enrolled
PostmenopauseHypertensionPre-Hypertension
Study Comparing Bioavailability of 3 New Formulations of Premarin/MPA With Premarin/MPA (PREMPRO) Reference Formulation
Started Nov 2006
Estrogen Replacement Therapy